Practice changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Mareike K. Thompson, Philip M Poortmans, Anthony J Chalmers, Corinne Faivre-Finn, Emma Hall, Robert A. Huddart, Yolande Lievens, David Sebag-Montefiore, Charlotte E. Coles

Research output: Contribution to journalArticlepeer-review

Abstract

As we mark 150 years since the birth of Marie Curie, we reflect on the global advances made in radiation oncology and the current status of radiation therapy (RT) research. Large-scale international RT clinical trials have been fundamental in driving evidence-based change and have served to improve cancer management and to reduce side effects. Radiation therapy trials have also improved practice by increasing quality assurance and consistency in treatment protocols across multiple centres. This review summarises some of the key RT practice-changing clinical trials over the last two decades, in four common cancer sites for which RT is a crucial component of curative treatment: breast, lung, urological and lower gastro-intestinal cancer. We highlight the global inequality in access to RT, and the work of international organisations, such as the International Atomic Energy Agency (IAEA), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the United Kingdom National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad), that aim to improve access to RT and facilitate radiation research. We discuss some emerging RT technologies including proton beam therapy and magnetic resonance linear accelerators and predict likely future directions in clinical RT research.
Original languageEnglish
Pages (from-to)389-407
JournalBritish Journal of Cancer
Volume119
Early online date31 Jul 2018
DOIs
Publication statusPublished - 2018

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Practice changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?'. Together they form a unique fingerprint.

Cite this